Global health services company Cigna had an up-and-down year. Despite bringing on an additional 8.4 million customers in its pharmacy division in 2021 and an 8.5% rise in sales, Cigna’s profits plummeted by 36% from 2020, to $5.37 billion. After years of litigation, an appeals court rejected Cigna’s attempt to claim a $1.85 billion breakup fee from Anthem in the wake of a merger agreement that fell apart a few years ago.
Brad Horrigan—Hartford Courant/Tribune News Service/Getty Images
Company Information
As of 3/29/23
Country
U.S.
Headquarters
Bloomfield, Conn.
Industry
Health Care: Pharmacy and Other Services
CEO
David M. Cordani
Website
Company Type
Public
Ticker
CI
Revenues ($M)
$180,516
Profits ($M)
$6,668
Market Value ($M)
$82,975
Employees
70,231
Figures are for fiscal year ended Dec. 31, 2022. Market value as of March 8, 2023. Sources: S&P Global; Bloomberg.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$174,078
8.5%
Profits ($M)
$5,365
-36.6%
Assets ($M)
$154,889
-
Total Stockholder Equity ($M)
$47,112
-
Profit Ratios
Profit as % of Revenues
3.1%
Profits as % of Assets
3.5%
Profits as % of Stockholder Equity
11.4%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
1,573
EPS % Change (from 2020)
-31.5%
EPS % Change (5 year annual rate)
16.9%
EPS % Change (10 year annual rate)
12.5%
Total Return
Total Return to Investors (2021)
12.3%
Total Return to Investors (5 year, annualized)
11.9%
Total Return to Investors (10 year, annualized)
18.8%
Cigna Rank History
Historical Data
Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
---|---|---|---|---|
2021 | $160,4014.5% | $8,45865.7% | $155,451 | $50,321 |
2020 | $153,566215.7% | $5,10493.6% | $155,774 | $45,338 |
2019 | $48,65016.9% | $2,63717.9% | $153,226 | $41,028 |
2018 | $41,6164.9% | $2,23719.8% | $61,753 | $13,735 |
2017 | $39,6684.7% | $1,867-10.8% | $59,360 | $13,723 |
SHOW MORE
Lists ranking Cigna
Latest news for Cigna
- Health
Health insurers justify passing COVID treatment costs on to patients despite massive profitsSeptember 23, 2021, 10:39 PM UTC - Leadership
Johnson & Johnson CEO Says Fix the Drug Pricing Process, But Not Too MuchDecember 4, 2018, 4:56 PM UTC - Health
What Carl Icahn Said In His Brutal Letter Slamming the Cigna-Express Scripts DealAugust 7, 2018, 2:18 PM UTC
- Brainstorm Health 2022 - Connected Health For All: Investigating In Access And Improved Outcomes;14:25Conferences, Brainstorm Health;
- Cigna CEO: We want to be the "undisputed partner of choice";7:51Series, On Leading;
- Karen Lynch's path to the C-Suite at CVS Health;;5:08
- Shifts in the Landscape;22:22Conferences, Brainstorm Health;